← SynDRA
METHSUXIMIDE
SynDRA canonical compound SYN0001464 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CACNA1G | CACNA1H | CACNA1I |
|---|
| Mechanism of action | T-type calcium channel blocker |
|---|
| Indication | seizures |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- CACNA1H BLOCKER
- Voltage-gated T-type calcium channel blocker
- CACNA1G BLOCKER
- CACNA1I BLOCKER
- T-type calcium channel blocker
Drug classes
- Anticonvulsants
- Central Nervous System Agents
- Anti-epileptic Agent
ATC classes
Cross-references
Synonyms
- mesuximid
- celontin
- mesuximide
- mesuximidum
- methsuximid
- racemic methsuximide
- (+/-)-Mesuximide
- Mesuximide
- Mesuximida
- NSC-760075
- Celontin
- Mesuximid
- Mesuximidum
- Methsuximid
- Metosuccimmide
- Metsuccimide
- Petinutin
- Methsuximide [BAN]
- Metosuccimmide [DCIT]
- PM 396
- Alpha-Methylphensuximide
- Celontin (TN)
- Mesuximida [INN-Spanish]
- Mesuximide (INN)
- Mesuximidum [INN-Latin]
- Methsuximide (USP)
- Petinutin (TN)
- Alpha-Methyl-alpha-phenyl N-methyl succinimide
- N,2-Dimethyl-2-phenylsuccinimide
- N-Methyl-alpha-methyl-alpha-phenylsuccinimide
- (+-)-N,2-Dimethyl-2-phenylsuccinimide
- (RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion
- 1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine
- 1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione
- 1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione
- 1,3-Dimethyl-3-phenylsuccinimide
- 1,3-dimethyl-3-phenylpyrrolidine-2,5-dione
- 2,5-Pyrrolidinedione,1,3-dimethyl-3-phenyl-, (+-)-
Reported adverse events
- Proteinuria
- Stevens-Johnson syndrome
Look up METHSUXIMIDE in the interactive SynDRA portal →